Welcome to Paid Research Studies




  • Conditions:   Advanced Pancreatic Cancer;   Advanced Solid Tumor
    Interventions:   Drug: Metformin;   Drug: Simvastatin;   Drug: Digoxin
    Sponsor:   John Nemunaitis, MD
    Recruiting

  • Conditions:   Postural Orthostatic Tachycardia Syndrome (POTS);   POTS;   Orthostatic Intolerance
    Interventions:   Drug: Pyridostigmine;   Drug: Digoxin;   Drug: Placebo
    Sponsors:   New York Medical College;   National Institutes of Health (NIH)
    Recruiting

  • Condition:   Acute Kidney Injury
    Interventions:   Drug: Digoxin Antibodies Fab Fragments;   Other: Placebo
    Sponsor:   University of Maryland, Baltimore
    Recruiting

  • Condition:   Congenital Heart Disease
    Intervention:   Drug: Digoxin
    Sponsors:   Christoph P Hornik, MD MPH;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The Emmes Company, LLC
    Not yet recruiting

  • Condition:   Severe Preeclampsia
    Interventions:   Biological: AMAG-423 (digoxin immune fab);   Other: Placebo
    Sponsor:   AMAG Pharmaceuticals, Inc.
    Recruiting

  • Condition:   Healthy Adult Subjects
    Interventions:   Drug: Omaveloxolone;   Drug: Midazolam oral solution;   Drug: Repaglinide 1 MG;   Drug: MetFORMIN 500 Mg Oral Tablet;   Drug: Rosuvastatin;   Drug: Digoxin tablet;   Drug: Gemfibrozil Tablets;   Drug: Itraconazole capsule;   Drug: Verapamil Pill
    Sponsors:   Reata Pharmaceuticals, Inc.;   Covance
    Recruiting

  • Conditions:   New Onset Atrial Fibrillation;   Sepsis;   Respiratory Failure
    Interventions:   Drug: Amiodarone in Parenteral Dosage Form;   Drug: Amiodarone Pill;   Procedure: Direct Current Cardioversion (DCC);   Drug: Rate-control therapy
    Sponsor:   Our Lady of the Lake Regional Medical Center
    Not yet recruiting

  • Conditions:   Fetal Atrial Flutter Without Hydrops;   Fetal Supraventricular Tachycardia Without Hydrops;   Fetal Supraventricular Tachycardia With Hydrops
    Interventions:   Drug: Digoxin (monotherapy);   Drug: Sotalol (monotherapy);   Drug: Flecainide (monotherapy);   Drug: Digoxin (dual therapy);   Drug: Sotalol (dual therapy);   Drug: Flecainide (dual therapy)
    Sponsors:   Edgar Jaeggi;   Canadian Institutes of Health Research (CIHR);   St George's, University of London
    Recruiting